KWF
Lead4Life PPP 2026 – Lead-212 Radiopharmaceuticals Program
12:00 noon; full proposal phase. Institutes not yet registered must submit a registration request at least 6 weeks prior to closing date.
Last verified:
Details
| Funder | KWF |
| Budget | €0.5M–€2M per project (total PPP subsidy: €5M) |
| Deadline | 22 September 2026 |
| Duration | Up to 4 years |
| Consortium | Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory |
| Application | 2-stage: matchmaking phase → full proposal phase (deadline 22 Sep 2026) |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Health~Holland PPP call for development of scalable lead-212 production technology and enabling technologies for clinical radiopharmaceutical application. Proposals must include a private party (not in financial difficulty) and comply with Health~Holland PPP requirements. Dutch-language summary required for Patient Advisory Committee review. Projects embedded in Lead4Life governance and national TRT network. Netherlands-based institutions; proposals submitted via KWF GMS.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
Proof Of Concept 2026-2
Deadline: 2 Jun 2026KWF Proof of Concept 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATKWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATINTER-LOCAL: International Call for Better Local Treatment of Rare and/or Hard to Treat Cancers
Deadline: 18 Jun 2026INTER-LOCAL: International Funding Call for Clinical Research on Local Treatment Strategies
Deadline: 18 Jun 2026Up to €3M
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free